Receptor Tyrosine Kinase-Mediated Angiogenesis
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The endothelial cell is the essential cell type forming the inner layer of the vasculature. Two families of receptor tyrosine kinases (RTKs) are almost completely endothelial cell specific: the vascular endothelial growth factor (VEGF) receptors (VEGFR1-3) and the Tie receptors (Tie1 and Tie2). Both are key players governing the generation of blood and lymphatic vessels during embryonic development. Because the growth of new blood and lymphatic vessels (or the lack thereof) is a central element in many diseases, the VEGF and the Tie receptors provide attractive therapeutic targets in various diseases. Indeed, several drugs directed to these RTK signaling pathways are already on the market, whereas many are in clinical trials. Here we review the VEGFR and Tie families, their involvement in developmental and pathological angiogenesis, and the different possibilities for targeting them to either block or enhance angiogenesis and lymphangiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“The current antiangiogenic drugs reduce tumor blood vessels, resulting in the “normalization” of the remaining vasculature, with less vascular leakiness, and improved pericyte coating and blood flow (Jain 2005).”
BackgroundFailure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931 · cited 2×
“5–9.5 as a result of defects in the development of hematopoietic and endothelial cells (Quinn et al. 1993; Shalaby et al. 1995).”
BackgroundInfluentialKim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122 · cited 1×
“1)—are largely restricted to the ECs in vertebrates, although they also are expressed in a few other cell types, notably in some hematopoietic cells (listed in the supplementary information S2 in Olsson et al. 2006).”
BackgroundRole of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606 · cited 1×
“Deletion of VEGFR-1 from mouse embryos results in a severely disorganized vasculature, which results from an increased commitment of mesenchymal precursor cells to the hemangioblast lineage (Fong et al. 1995, 1999).”
BackgroundHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 2×
“Tumor vascularization correlates with hematogenous metastasis (Weidner et al. 1991; Graeber et al. 1996) and VEGF-A or VEGFR-2 have provided prognostic markers for metastasis in some studies (Bremnes et al. 2006).”
BackgroundIsolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989 · cited 1×
“1) function as ligands for Tie2 (Davis et al. 1996; Maisonpierre et al. 1997; Kim et al. 1999; Valenzuela et al. 1999; Lee et al. 2004).”
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691 · cited 2×
“Also, a VEGFR-1/VEGFR-2 fusion protein, VEGF-A-Trap, was described as a potent anti-VEGF-A suppressor of tumor growth and vascularization in vivo (Holash et al. 2002).”
BackgroundTonnesen, M. G., Feng, X., & Clark, R. A. F. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00014.x · Cited by 1,463
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Fantin, A., Vieira, J. M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S. W., & Ruhrberg, C. (2010) · Blood · doi:10.1182/blood-2009-12-257832 · Cited by 1,153 · cited 1×
“This process is regulated by neuropilin signaling and macrophages that accompany angiogenic processes (Gerhardt et al. 2004; Fantin et al. 2010).”
BackgroundDumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933 · cited 1×
“Ang2 is locally released from the secretory storage granules at sites of endothelial activation, and it acts as a proinflammatory molecule by sensitizing the endothelium, for example, to the tumor necrosis factor-a-induced expression of endothelial cell adhesion molecules (Fiedler et al. 2006).”
BackgroundControl of hair growth and follicle size by VEGF-mediated angiogenesis
Yano, K., Brown, L. F., & Detmar, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11317 · Cited by 710 · cited 2×
“…and VEGF-A receptor expression—include wound healing and tissue repair (Tonnesen et al. 2000), exercise-induced angiogenesis in the heart and skeletal muscle (Prior et al. 2004), the hair cycle (Yano et al. 2001), and, in the female, reproductive cycle and placenta development (Augustin 2005).”
BackgroundExcess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans
Parikh, S. M., Mammoto, T., Schultz, A., Yuan, H.-T., Christiani, D., Karumanchi, S. A., & Sukhatme, V. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030046 · Cited by 527 · cited 2×
“Ang2 levels are increased in tumor patients and in numerous diseases characterized by vascular leakage and inflammation, for example, in sepsis (Parikh et al. 2006).”
BackgroundAngiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
Felcht, M., Luck, R., Schering, A., Seidel, P., Srivastava, K., Hu, J., Bartol, A., Kienast, Y., Vettel, C., Loos, E. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58832 · Cited by 479 · cited 1×
“Angiopoietins may also directly bind to integrins, and this may regulate the functions of tip cells, which express high levels of Ang2 but low Tie2 levels (del Toro et al. 2010; Felcht et al. 2012).”
BackgroundIdentification and functional analysis of endothelial tip cell–enriched genes
del Toro, R., Prahst, C., Mathivet, T., Siegfried, G., Kaminker, J. S., Larrivee, B., Breant, C., Duarte, A., Takakura, N., Fukamizu, A., et al. (2010) · Blood · doi:10.1182/blood-2010-02-270819 · Cited by 474
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling
Tammela, T., Zarkada, G., Nurmi, H., Jakobsson, L., Heinolainen, K., Tvorogov, D., Zheng, W., Franco, C. A., Murtomäki, A., Aranda, E., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2331 · Cited by 321 · cited 2×
“Furthermore, VEGF-A and VEGF-C both promote collecting lymph vessel enlargement, increased lymph flow, lymph node lymphangiogenesis, and lymphatic metastasis (He et al. 2002; Roberts et al. 2006; Tammela et al. 2011a).”
BackgroundSelf-citationEffects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis
Holopainen, T., Saharinen, P., D’Amico, G., Lampinen, A., Eklund, L., Sormunen, R., Anisimov, A., Zarkada, G., Lohela, M., Heloterä, H., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs009 · Cited by 216
Self-citationOligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500292200 · Cited by 170 · cited 1×
“The angiopoietins comprise a structurally unique family of growth factor ligands that multimerize to form various-sized multimers with multiple receptor-binding domains (Kim et al. 2005).”
BackgroundCrystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1101 · Cited by 134 · cited 1×
“1) (Barton et al. 2006; Macdonald et al. 2006).”
Thomas, M., Felcht, M., Kruse, K., Kretschmer, S., Deppermann, C., Biesdorf, A., Rohr, K., Benest, A. V., Fiedler, U., & Augustin, H. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.097543 · Cited by 101 · cited 1×
“Ang2 regulates Tie2 localization in an integrin-dependent manner (Pietila et al. 2012), and induces clustering of Tie2 and b3 integrins in cell–cell junctions stimulating integrin turnover (Thomas et al. 2010).”
Background
Cited by
Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Ramakrishnan, S., Anand, V., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9531-7 · Cited by 442
VEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
Tie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283
“Vascular integrity and remodeling are governed by the cooperative interaction of endothelial growth factors and inflammatory cytokines (3).”
BackgroundSelf-citationDimerization of Tie2 mediated by its membrane-proximal FNIII domains
Moore, J. O., Lemmon, M. A., & Ferguson, K. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617800114 · Cited by 30
Metadata
- Authors
- Jeltsch, M., Leppanen, V.-M., Saharinen, P., & Alitalo, K.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2013-09-01
- Volume
- 5
- Issue
- 9
- Pages
- a009183-a009183
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2117743783
- Cited by
- 175
- References
- 23
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.